Rapid titrimetric and spectrophotometric methods for salbutamol sulphate in pharmaceuticals using N-bromosuccinimide
One titrimetric and two spectrophotometric methods which are simple, sensitive and rapid are described for the assay of salbutamol sulphate (SBS) in bulk drug and in tablet dosage forms using N-bromosuccinimide (NBS) and two dyes, rhodamine-B and methylene blue, as reagents. In titrimetry, aqueous solution of salbutamol sulphate is treated with a measured excess of NBS in acetic acid medium and after the oxidation of SBS is complete, the unreacted oxidant is determined iodometrically. Spectrophotometric methods entail addition of a known excess of NBS in acid medium followed by the determination of residual oxidant by reacting with a fixed amount of either rhodamine B and measuring the absorbance at 555 nm (method A) or methylene blue and measuring the absorbance at 665 nm (method B). In all methods, the amount of NBS reacting corresponds to the amount of SBS content. Titrimetric method is applicable over 1.74 x 10-4 - 8.68 x 10-4 mol L-1 range and the reaction stoichiometry is found to be 1:6 (SBS:NBS). In spectrophotometric methods, the absorbance is found to increase linearly with the concentration of SBS, which is corroborated by the correlation of coefficients of 0.9993 and 0.9988 for method A and method B, respectively. The systems obey Beer's law for 0.25-1.75 μg mL-1 (method A) and 0.5-5.0 μg mL-1 (method B). The calculated apparent molar absorptivity values were found to be 2.10 x 105 and 6.16 x 104 L mol-1 cm-1, for method A and method B, respectively. The limits of detection and quantification are also reported for both spectrophotometric methods. Intraday and inter-day precision and accuracy for the developed methods were evaluated. The methods were successfully applied to the assay of SBS in tablet and capsule formulations and the results were statistically compared with those of a reference method. No interference was observed from common tablet adjuvants. The accuracy and reliability of the methods were further ascertained by recovery experiments via the standard-addition technique.
European Pharmacopoeia, 5th ed., vol. II, EDQM, Strasbourg 2005, p. 3611.
The British Pharmacopoea, Her Majesty's Stationery Office, London 1998, pp. 1151-1152.
Indian Pharmacopoea, The Controller of Publications, Ministry of Health and Family Welfare, Government of India, New Delhi 1996, pp. 670-673.
T. L. Bernal, M. J. del-Nozal, H. Velasco and L. Toribio, HPLC versus SFC for the determination of salbutamol sulphate and its impurities in pharmaceuticals, J. Liq. Chromatogr. Rel. Technol. 19 (1996) 1579-1589.
S. Ray and A. Bandopadhyay, Reversed phase high performance liquid chromatographic determination of salbutamol sulphate in pharmaceutical formulations, Indian Drugs 27 (1990) 313-316.
R. A. Singh, Kumar, D. Kumar and A. K. Agarwal, Simultaneous estimation of cetirizine hydrochloride and salbutamol sulphate in pharmaceutical dosage forms by reverse phase high performance liquid chromatography, Pharma Rev. 3 (2005) 144-146.
N. Talwar, A. K. Singhai, A. K. Shakya, S. Saraf and N. K. Jain, Difference spectrophotometric determination of salbutamol sulphate in tablets, Indian Drugs 28 (1991) 244-245.
I. H. I. Habib, M. E. M. Hassouna and G. A. Zaki, Simultaneous spectrophotometric determination of salbutamol and bromhexin in tablets, Farmaco 60 (2005) 249-254.
N. P. Sadler and H. Jacobs, Application of the Folin-Ciocalteau reagent to the determination of salbutamol in pharmaceutical preparations, Talanta 42 (1995) 1385-1388.
D. Satinsky, R. Karlicek and A. Svaboda, Using on-line solid phase extraction for flow injection spectrophotometric determination of salbutamol, Anal. Chim. Acta 455 (2002) 103-109.
M. N. Reddy, D. G. Sankar, G. D. Rao and K. Sreedhar, Spectrophotometric determination of salbutamol and terbutaline, East. Pharm. 34 (1991) 127-128.
M. Basu and B. Pathak, Estimation of salbutamol sulphate in pharmaceutical formulations, Indian Drugs 28 (1990) 109-110.
N. Geetha and T. R. Baggi, Improved spectrophotometric method for the determination of salbutamol sulphate with 3-methyl benzothiazolin-2-one hydrazone, Microchem. J. 39 (1989) 137-144.
N. V. Naidu, D. V. Naidu, C. V. Rajeshwari and P. R. Naidu, Simple spectrophotometric determination of salbutamol sulphate in pharmaceutical formulations, Acta Chim. Hung. 126 (1989) 821-824.
K. K. Vishwanth, A. S. Rao and M. V. Shivaramakrishnan, Colorimetric determination of salbutamol in pharmaceutical preparations, Indian Drugs 26 (1989) 516-518.
R. B. Patel, A. S. Patel and U. Pallavi, Spectrophotometric determination of salbutamol sulphate and its combination in pharmaceutical dosage forms, Indian Drugs 24 (1987) 298-302.
N. M. Sanghavi and J. T. Vyas, Use of nitrating agent in the colorimetric estimation of drugs - Part II, Indian Drugs 34 (1997) 463-466.
R. S. Bakry, A. F. El-Walily and S. F. Belal, Spectrophotometric determination of etilefrine, ritodrine, isoxsuprine and salbutamol by nitration and subsequent Meisenheimer complex formation, Anal. Lett. 28 (1995) 2503-2519.
G. G. Mohammed, S. M. Khalil, M. A. Zayed and M. Abd El-Hamid El-Shall, 2,6-Dichloroquinone chlorimide and 7,7,8,8-tetracyanoquino-dimethane reagents for the spectrophotometric determination of salbutamol in pure and dosage forms, J. Pharm. Biomed. Anal. 28 (2002) 1127-1137.
N. Geetha and T. R. Baggi, Microtitrimetric determination of salbutamol sulphate using N-bromosuccinimide, Mikrochim. Acta 1990, 95-99.
Y. M. Issa, A. F. Shoukry and R. M. El-Nashar, Conductometric determination of reproterol HCl and pipazethate HCl and salbutamol sulphate in their pharmaceutical formulation, J. Pharm. Biomed. Anal. 26 (2002) 379-386.
A. Berka, J. Vulterin and J. Zyka, Newer Redox Titrants, Pergamon Press, New York 1965, pp. 53.
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2(R1), Complementary Guideline on Methodology dated 06 November 1996, incorporated in November 2005, London.